FDA Expands Bivalent COVID-19 Booster Eligibility for Vulnerable Populations
New Guidance for High-Risk Groups The U.S. Food and Drug Administration (FDA) announced on Tuesday an amendment to its emergency use authorizations, permitting individuals aged 65 and older and those with specific immunocompromising conditions to receive an additional dose of the bivalent COVID-19 vaccine. This regulatory shift allows vulnerable populations across the United States to…